Blood pressure drug shows promise in slowing Parkinson's progression
NCT ID NCT05109364
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether terazosin, a drug usually used for high blood pressure, can slow the progression of Parkinson's disease. Researchers are tracking changes in heart and brain scans of 15 people who are either in early stages or at high risk for Parkinson's. The goal is to see if the drug can protect nerve cells and delay symptoms over three years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-MOTOR PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists track rare brain diseases to uncover early warning signs
- Could a new pill calm brain inflammation and slow Parkinson's-Linked sleep disorder?
- Could head injuries trigger a strange sleep disorder? new study investigates
- Gut check: could your intestines hold clues to Parkinson's and MS?
- Sleep disorder study could pave way for Parkinson's prevention
- Brain scans could reveal early warning signs of Parkinson's